As a company, we are committed to investing in the resources that will ultimately deliver the most advanced left-ventricular assist device
available to help patients retain a healthy and meaningful quality of life while awaiting a heart transplant or ultimately as a long-term solution to a failing heart.
Last year, the agency approved clinical trials for Stanford University Medical Center's left-ventricular assist device
, which takes over the heart's muscular workhorse, the left ventricle, during heart transplants or open-heart surgery.
AMEX: TCA) announced today that Gloria Dorame, a 55-year-old patient in San Diego, has been supported by the company's HeartMate(R) left-ventricular assist device
for 733 days, the longest on record.
When it is developed, the continuous flow pump initially will serve as a "bridge" for patients awaiting heart transplantation, as does the HeartMate(R), another left-ventricular assist device
now in use.